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cDNA clones coding for the B-chain of murine Clq were isolated from a mouse macrophage library. The characterized clones include the total 
coding region plus a leader sequence. High homology was found with human Clq B-chain in the coding region (81%). Northern blot analysis of 
total RNA from different tissues of Balb/c mice showed one band of approximately 1.2 kb. The highest signal was found in RNA preparations 
of thioglycolate-activated peritoneal macrophages. The probe also hybridized with mRNA from spleen, thymus and heart. Extremely weak signals 
were found in liver, kidney, lung and intestine tissues. 
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1. INTRODUCTION 
Clq is a subcomponent of the first component of 
complement, that initiates the classical pathway by bin- 
ding to the Fc-portion of immunoglobulins or to polya- 
nions [ 11. Murine Clq has been purified and 
characterized from serum, plasma and ascites fluid. 
The biochemical, physical and biological properties 
show high similarities to human Clq [2-51. 
[15,16]. Production of Clq by cultured human 
monocyte derived macrophages has recently been 
described [ 171. 
We now present the molecular cloning and sequenc- 
ing of the B-chain of murine Clq and the detection of 
Clq in different tissues by Northern blot analysis. 
2. MATERIALS AND METHODS 
The site of biosynthesis of Cl and Clq in particular 
has been the topic of some controversy. In early biosyn- 
thetic labelling experiments and functional tests, Cl 
and Clq synthesis was demonstrated in epithelial cells 
of the small intestine of guinea pigs [6] and intestinal 
tissue of the piglet [7]. Since Clq is a collagen-like 
molecule, the synthesis by collagen-producing cells was 
investigated. The synthesis of Clq and Cl by human 
fibroblast cell lines could be demonstrated using im- 
munoprecipitation and hemolytic assay [8,9]. In con- 
trast, there is no evidence to indicate Cl synthesis in a 
fibroblast cell line [lo]. Although Clq biosynthesis was 
found in primary cultures of guinea pig hepatocytes 
[ 1 I], no production could be shown in a hepatoma cell 
line Hep G3 [ 121 or in human liver tissue [ 131. Human 
and primate peritoneal and alveolar macrophages have 
been reported to synthesize the 11 S globulin identified 
as Clq [14]. De novo synthesis of Clq by cultured 
mouse, guinea pig and human macrophages has been 
intensively studied and antigenic identities between 
serum Clq and macrophage-derived Clq was shown 
2.1. Isolation of cDNA clones 
A mouse alveolar macrophage cDNA library established in the 
bacteriophage hgtll (ML 1005, Clontech Lab., Palo Alto, CA) was 
screened by using a human Clq B-chain cDNA probe [18]. A 
PvuWStuI restriction fragment [19] was prepared and radioactively 
labeled by nick translation [20]. Recombinant phage plaques were 
screened in duplicate on nitrocellulose filter replicas [23]. The filters 
were hybridized in hybridization solution supplemented with 10% 
dextran sulfate plus 2 x lo5 counts per minute (cpm)/ml (spec. act. 
10’ cpm/Fg DNA) nick translated probe for 16 h at 42°C. Filters 
were finally washed in 4 x standard salt concentration @SC; 
150 mM NaCI, 15 mM sodium citrate) plus 0.1% SDS for 60 min at 
65°C. Air-dried filters were autoradiographed at -70°C with intensi- 
fying screens. Positive plaques were rescreened and purified. ADNA 
was prepared by standard techniques [21]. Two clones designated B15 
and B18 were finally subcloned into the PvuII site of the plasmid vec- 
tor PAT 153/PvuII/8 [22]. 
2.2. Sequence analysis 
Sequencing was done in bacteriophage M13mp8 by the dideoxy 
chain-termination method 1231, using deoxyadenosine 
5 ‘-[cu-%]thiotriphosphate (Amersham, Braunschweig, FRG) and Se- 
quenase (US Biochemical Corp., Cleveland, OH). Sequence data 
analysis was carried out using the PC/GENE nucleic acid and protein 
sequence analysis packages (Genofit, Grand-Lancy, Switzerland). 
2.3. Northern blot analysis 
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Mouse peritoneal macrophages were obtained from thioglycollate 
stimulated male Balb/c mice [24] and purified by adhesion onto 
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tissue cutture plates (petri perm, Heraeus, Hanau, FRG) at 37%’ for 
4 h. The mouse macrophage-like cell line PU5-1.8 was grown in 
RPM&medium supplemented with glutamine (2 mM), penicillin 
(50 W/ml) and streptomycin (50,&ml). RNA was extracted from 
mouse tissues and cell suspensions by the guanidine thio- 
cyanate/caesium chloride method 1251. 
RNA samples (20 ag) were denatured and electrophoresed in a 1% 
agarose gel containing 0.66 M formaldehyde and blotted overnight 
onto nylon fikers (Gene Screen, New England Nuclear, Dreieich, 
FRG) [26]. Single-stranded anti-sense cDNA probes of mouse Clq B- 
chain were radioactively labeled by primer extension of Ml3 
subclones B15-501 and B18-532 [26] (see fig.1). Hybridization was 
performed in a buffer containing 10% dextran sulfate and 50% for- 
mamide at 42’C for 20 h. The nylon filters were washed twice with 
2 x SSC plus 1% SDS for 30 min at 65°C and finally twice with 0.1 
x SSC plus 1% SDS for 30 min at room tem~rature. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and nucleotide sequence of mouse Clq 
E-chain cDNA clones 
The pVuII/StuI restriction fragment of the cDNA 
clone coding for the human Clq B-chain was chosen 
because it spans almost the entire coding sequence of 
the native protein but excludes all non-coding and 
signal sequences. 
Approximately 750~ recombinant phage plaques 
were screened and 24 positive signals were obtained. 
leader 
sequence collagen-like legion 
The insert size of the Xgtl 1 clones that were subcloned 
into pAT 153/hluII/8 was estimated by EcoRI diges- 
tion and agarose gel electrophoresis. AB15 and XB18 
had inserts of about 900 bp and 850 bp, respectively. 
BamHI and MspI restriction fragments of plasmid 
clones pB15 and pB18 were subcloned in M13mp8. 
Fig.1 shows the sequence strategy and restriction map 
of mouse Clq B-chain. The sequencing was done in 
both orientations. In addition to deox- 
yadenosinetriphosphate, deoxyinosinetriphosphate was 
used in Ml3 subclones B15-410 and B15-501 to over- 
come the problems of band compression in G-C-rich 
regions [27]. 
The two recombinant Agtll clones B15 and B18 
cover the total coding region (684 bp) and a leader se- 
quence (75 bp) containing an in-phase start codon. This 
leader sequence is identical to the N-terminal of 
secretory signal sequence computed by the PC/GENE 
program PSIGNAL [28]. The cDNA clones include a 
5 ’ -noncoding region of 11 bp and a 3 ’ -noncoding 
region of 151 bp (see fig.2). The mouse Clq B-chain 
coding region was found to be highly homologous to 
that of human Clq (81% in the nucleotide sequence, 
83% in the deduced amino acid sequence). The 
homologies of the mouse and human Clq B-chain 
globular region 
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Fig. 1. Cloning strategy and restriction map of murine Clq B-chain cDNA clones. 
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signal peptide and the 3 ‘-untranslated region were 
found to be 60% and 52070, respectively. 
A change in the nucleotide sequence at position 112 
(C versus G) results in replacement of the Ala residue 
(amino acid position 9) in the human sequence with a 
Gly residue in the mouse. As a consequence the 
collagen-like region starts two Gly-Xxx-Yyy- repeats 
earlier in the mouse sequence. Two additional amino 
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Fig.2. The cDNA sequence of the B-chain of mouse Clq. The bar represents the collagen-like region. The boxed sequence shows the positions 
of two additional amino acids found in the mouse sequence on comparison with the human sequence. The nucleotide and amino acid sequences 
of the B-chain of human Clq are given at only the position where there is a difference seen on comparison with the mouse sequences. 
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acids (Ser and Met at positions 165 and 166) are not 
present in the human sequence. The 4 Cys are com- 
pletely conserved, between mouse and man, and the 
residues adjacent to these Cys residues are also highly 
conserved. While this work was in process a nucleotide 
sequence of the murine Clq B-chain was published 
[29]. The two sequences are almost identical with the 
following exceptions: nucleotide positions 6 and 7 in 
our sequence are C and G versus G and A in the se- 
quence of Wood et al. [29]. Within the coding se- 
quences, nucleotide positions 59, 134, 164, 179 and 182 
in our sequence read C, C, A, A and G versus T, T, T, 
T and A in that of Wood et al. All 5 positions are last 
bases of a codon and do not result in a change of the 
deduced amino acid sequence. A discrepancy at posi- 
tion 354 (A versus G) leads to an Arg (AGG) residue in 
our sequence instead of a Gly (GGG). According to our 
sequence data, the C-terminus of the collagen-like 
region appears identical in both the mouse and human 
sequences. 
Alignment of the mouse sequence with the human se- 
quence shows two additional residues, Ser and Met, in 
the deduced amino acid sequence of the mouse at posi- 
tions 165 and 166, using the genetic code matrix of the 
PC/GENE PALIGN-program [30]. This results in a 
greater homology than that produced by the insertion 
of Asp and Arg (positions 162 and 163) reported by 
Wood et al. [29]. 
At positions 815 and 817 we found two additional C 
nucleotides; as a consequence alignment of the mouse 
DNA sequence with the human DNA sequence results 
in a 52% homology instead of 47% [29]. Two 
nucleotides at position 915 and 916 read CG in the se- 
quence reported here, instead of AA in that reported by 
Wood et al. [29]. 
3.2. Biosynthesis of the B-chain of Clq by mouse 
tissues 
Northern blot analysis of total RNA revealed one 
band of approximately 1.2 kb (fig.3). This indicates 
that the complete mRNA of the Clq B-chain is about 
0.3 kb longer than the characterized cDNA clones. The 
highest signal was found in RNA preparations of 
thioglycollate activated peritoneal macrophages. In 
contrast, no signal was obtained in the macrophage-like 
cell line PUS-1.8. The murine B-chain probes also 
hybridized with a 1.2 kb band of RNA from the lym- 
phoid organs, spleen and thymus. The hybridization 
signal with mRNA from heart tissue is not quite 
understood. A pathological infiltration of 
macrophages into the pericard or endocard can be ex- 
cluded. The signal is probably due to resident 
macrophage-type cells rather than cardiac muscle cells. 
Extremely weak signals were found in kidney, lung, 
intestine, and muscle RNA. In addition, it is of interest 
to note that even in the liver, the major site of biosyn- 
thesis of most complement components, only minute 
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Fig.3. Northern blot analysis of total RNA from different mouse 
tissues. Filter hybridized with single stranded probe BlS-501. 
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Fig.4. Northern blot analysis of total RNA from different mouse 
tissues. (A) Filter hybridized with single stranded probe B15-532. (B) 
Filter B hybridized with nick translated ru-actin probe pAC 269 [31]. 
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amounts of mRNA coding for the B-chain of Clq were 
detectable. These weak hybridization signals could be 
produced by tissue-macrophages or other macrophage- 
like cells, e.g. liver Kupffer cells. 
The use of an actin DNA probe (fig.4A) as a control 
indicated that the weak signals in most of these tracks 
were not due to a lower loading of mRNA compared to 
the tracks giving a strong signal with the Clq probe. 
The differences in size and intensity of the signals with 
the cY-actin probe pAC 269 [31] are due to the fact that 
@-actin mRNA (1.6 kb) is only found in skeletal mus- 
cle. The a-actin probe hybridized well with a mRNA 
from cardiac tissue of similar size. cu-Actin shows 70% 
sequence homology with the nonmuscle & and y-actin 
sequences [31] and hybridized with a 1.9 kb mRNA. 
These studies described the isolation and 
characterization of the cDNA coding for the B-chain of 
mouse Clq. Using this cDNA as a probe for the detec- 
tion of the B-chain mRNA in cells and tissues, it was 
found that macrophages have to be considered as a ma- 
jor site of Clq biosynthesis. 
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